6505--VA Phoenix and Tucson Radiopharmaceuticals IDIQ
Veterans Affairs · 262-NETWORK CONTRACT OFFICE 22 (36C262)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26226Q0334 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
This is a combined synopsis/solicitation unrestricted/full and open for commercial supplies prepared in accordance with the format in Subpart 12.6, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for quotes under solicitation number: 36C26226Q0299 The Department of Veterans Affairs Network Contracting Office (NCO) 22 is looking for a contractor who can supply variety radiopharmaceuticals listed below for VA Phoenix and VA Tucs… (show all)
on Healthcare System located in Arizona. The Contractor shall furnish all supplies/services at participating VA medical centers. Shipping term is FOB Destination. Shipping must be included in the unit cost. The Government intends to award a firm fixed-price single award Indefinite Delivery Indefinite Quantity (IDIQ) contract for base plus option four years. VAAR 852.212-71 Gray Market and Counterfeit Items apply on this acquisition. No remanufacturers or gray market items will be acceptable. Vendor shall be an Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor or authorized reseller verified by an authorization letter or other documents from the OEM signed. The letter must either state specific product(s) quoted or that the quoter is an authorized distributor for all the manufacturer s products. This letter must be on the manufacturer s letterhead and contains the signature of an authorized official for the manufacturer. Description/Part Number* Tc99m Pertechnetate Tc99m MDP Tc99m Sulfur Colloid Egg Tc99m DTPA Tc99m DTPA aerosol Tc99m MAA reduced particles Tc99m MAA I-123 Capsule 100uCi I-123 Capsule 200uCi I-123 Capsule 400uCi I-131 Capsule I-131 Capsule per mCi I-131 Source Xe-133 (10mCi) Xe-133 (20mCi) Tc99m Pertechnetate bulk Tc99m Sulfur Colloid (Liver, bone marrow) Tc99m Filtered Sulfur Colloid Lymph Tc99m non-Filtered Sulfur Colloid Lymph Tc99m Choletec/Mebrofenin In-111 DTPA vial Ultratag kits Tc99m Sestamibi Parathyroid Tc99m Cardiolite Tc99m Myoview Tc99m Ceretec Brain Tc99m MAG3 Tc99m DMSA Tc99m HMPAO WBC Ga-67 per mCi Tc99m Pertechnetate Instavent kit Aerovent Tc99m Pyrophosphate Cold Pyrophasphate In-111 Pentreotide UD In-111 Chloride source In-111 WBC Oxine I-123 MIBG Quadramet Cu-64 DOTATATE I-131 Albumin Source I-131 Albumin Syringe I-131 Albumin Source I-131 Albumin Blood Volume Analysis Tc99m Neurolite Xenon Conv Kit SS Mask w/DD, Fltr, Tbg Soda Lime CO2 Absorber 1lb Drierite 1lb Ra-223 Disochloride UD uCi Cu-64 Dotatate UD F-18 FDG F-18 Sodium Fluoride F-18 Calibration Dose Ga-68 DOTATATE Ga-68 Locametz Ga-68 Illucix The solicitation will be in accordance with FAR Part 12, 13, and Subpart 16.5, Acquisition of Commercial Items, Simplified Acquisition Procedures, Indefinite-Delivery, and Veteran Affairs Acquisition Regulations as supplemented with additional information in this notice. The North American Industrial Classification System (NAICS) code for this requirement is 325412, Size Standard 1,300 Employees. The Contractor shall adhere to all federal and state laws and regulations in effect during the term of this contract. The Government intends to award a firm-fixed-price contract. The Contract begins on the date of award. System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in agency solicitations. Examples include 52.222-25, Affirmative Action Compliance, and paragraph (d) of 52.212-3, Offeror Representations and Certifications Commercial Products and Commercial Services. Contracting officers will not consider these representations when making award decisions or enforce requirements. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM. In advancement of Section 2 of Executive Order 14208, the removal of requirements related to Executive Order 14057 eliminates all non-statutory sustainability requirements or preferences in purchases of food service wares, including paper straws. In addition to removing requirements related to Executive Order 14057, the attachment also reflects recent updates to Code of Federal Regulation citations for the U.S. Department of Agriculture s BioPreferred® Program, a statutory purchasing preference program. Key solicitation milestones are: Submit any questions regarding this procurement via email to Hestia.Sim@va.gov no later than 10am Pacific Local Time Friday, February 6, 2026. No questions will be answered after this date/time unless determined to be in the best interest of the Government as determined by the Contracting Officer. Telephonic questions will not be accepted or returned. RFI responses will be responded to as necessary in amendment format which will be posted to contract opportunities at http://SAM.gov. Due to time constraints, responses to the solicitation shall be due on Friday, February 13, 2026 at 10:00 Pacific Time. Offerors are advised that it is your responsibility to review and monitor the website frequently to ensure you have the most up to date information, including amendments. Correspondence or questions may be directed to Hestia Sim, Contracting Specialist at Hestia.Sim@va.gov with 36C26226Q0299, VA Phoenix and Tucson Radiopharmaceuticals IDIQ in the subject line within 48 hours of release of this notice. Telephone inquiries will not be honored. Inquiries after the allotted period may not be responded to due to the time constraints of the procurement. All offerors must be registered in www.sam.gov to do business with the Government. Ensure your registration is correct, current and has not expired. Please use the attached spreadsheet, B.3 Price Cost Schedule, to provide pricing for each radiopharmaceutical for the base period plus option years. Contractors may use their own versions; however, it must include all required information (pricing of each radiopharmaceutical, estimated total cost per year, and estimated total cost for base plus option four years) and mirror the structure provided. It is the contractor's responsibility to ensure the accuracy of all calculations and to double check that the excel format is correct.
Who won similar work
25 award notices on SAM.gov in the last 24 months. Matched by: Same office (262-NETWORK CONTRACT OFFICE 22 (36C262)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (25): middle half $496K to $3.5M, median $1.8M; range $53K to $37.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| EXELAN PHARMACEUTICALS INC | 9 | $42.2M | Jan 28, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH · $254.2B | 4 | $929K | Oct 1, 2026 |
| Novartis Pharmaceuticals Corporation | 2 | $8.9M | Jan 8, 2026 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | 2 | $6.4M | Dec 16, 2024 |
| BOSTON SCIENTIFIC CORP · $BSX · $21.0B | 2 | $1.4M | Dec 23, 2025 |
| PROGENICS PHARMACEUTICALS INC | 2 | $1.2M | Aug 21, 2025 |
| SIRTEX MEDICAL INC | 1 | $37.3M | Nov 12, 2025 |
| TELIX PHARMACEUTICALS US INC | 1 | $496K | Apr 22, 2026 |
| Bristol-Myers Squibb Company | 1 | $364K | Jun 30, 2026 |
| RLS (USA) INC. | 1 | $320K | Dec 10, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $CAH reported $254.2B revenue (fiscal year ending Jun 30, 2026). The median single-winner award in these 25 past awards, $1.8M, is under 0.1% of that. SEC filing
- $BSX reported $21.0B revenue (12 months to Jun 30, 2026). The median single-winner award in these 25 past awards, $1.8M, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026CARDINAL HEALTH 414, LLC$53K6505--VALL Iodine Isotope IDIQMateriality: <0.01% of $CAH revenue (Low) SEC
- Jun 30, 2026Bristol-Myers Squibb Company$364K6505--Emergency BreyanziMateriality: <0.01% of $BMY revenue (Low) SEC
- Apr 22, 2026TELIX PHARMACEUTICALS US INC$496K6505--VA San Diego PSMANo listed company matched (Materiality N/A)
- Mar 18, 2026CARDINAL HEALTH 414, LLC$259K6505--VA San Diego and Phoenix Lymphoseek IDIQMateriality: <0.01% of $CAH revenue (Low) SEC
- Jan 28, 2026EXELAN PHARMACEUTICALS INC$3.3M6505--VA San Diego Lenalidomide DONo listed company matched (Materiality N/A)
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$2.1M6505--VA Loma Linda Lenalidomide DONo listed company matched (Materiality N/A)
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$2.5M6505--VA Phoenix Lenalidomide DONo listed company matched (Materiality N/A)
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$3.7M6505--VA Long Beach Lenalidomide DONo listed company matched (Materiality N/A)
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$2.1M6505--VA Albuquerque Lenalidomide DONo listed company matched (Materiality N/A)
- Jan 14, 2026EXELAN PHARMACEUTICALS INC$1.8M6505--VA Prescott Lenalidomide DONo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (10 filings)
- 1 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $63K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 3 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 5 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.